Immunai and Boehringer partner to identify T-cell targets
The collaboration will see the companies gather and analyse data from many patient samples.
Drug Development
Ionis grants Recordati rights to zilganersen for Alexander disease
MSD’s Keytruda-Padcev combo secures EC approval for MIBC
RQ Bio secures $115m to develop influenza antibody programme
Boehringer and Combotope partner for cancer antibodies
Haisco and Nuvectis sign licensing deal for two drugs
Genprex’s Reqorsa combo secures Canadian patent for lung cancer
Lilly and BioArctic sign deal to develop neurodegenerative therapy
